SL BIGEN   Report issue

For profit Phase 1
Founded: Seongnam Korea, Republic of (1954)

Organization Overview

First Clinical Trial
2018
NCT03576014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

SL BIGEN | SL VAXiGEN